Live·Open questions in longevity research
← Questions

Can aging human skin be shifted into a stable, youthful functional state, and what minimal set of changes in cells, the extracellular matrix, stem cell niches, the vasculature, and the nervous system is necessary and jointly sufficient to achieve and maintain this transition?

Does restored dead-cell removal stop skin damage after repeated challenges, or can aged surrounding tissue restart it?

In the proposed cycle, failure of the protective barrier contributes to inflammation, inflammation disrupts supporting tissue, and that disruption makes barrier recovery harder. Removing dead cells could interrupt a contributing source of inflammation, allowing recovery to continue.

The whole reason

However, the supplied sources associate increased clearance with both repair-supporting changes and scar formation, so improved clearance alone cannot establish recovery of normal tissue organization [S1, S3]. If surrounding aged tissue restarts damage despite continued clearance, treating clearance as sufficient would mistake an early improvement for a lasting change. Conversely, lasting recovery through repeated challenges would support the narrower conclusion that continuing aged-tissue effects did not restart the measured damage under those conditions.

The question in full

The question concerns whether restoring dead-cell removal can produce lasting recovery in aging human skin. It asks whether macrophages, immune cells that clear dead cells, can interrupt a proposed cycle in which damage to the skin’s protective barrier and its supporting material reinforces further damage. The competing possibility is that aged stroma, the surrounding support cells and material, restarts this cycle even while dead-cell removal remains normal during repeated mild challenges to the barrier. The intended comparison is lasting recovery versus returning damage, measured through barrier sealing, inflammation, and the arrangement of supporting material relative to young skin, ultimately over twenty years. The question assumes that this reinforcing cycle exists and that surrounding aged tissue might sustain it independently of defective clearance; the supplied sources do not establish that complete mechanism.

What is in dispute

Each route below is a way this could work. They predict different things for the same measurement, which is what makes the question answerable at all.

  1. 01Restored corpse clearance can worsen aged skin by removing recoverable living cellsIn donor-matched organotypic skin, restoring macrophage corpse clearance may remove living cells needed for repair. Protecting recoverable basal keratinocytes must restore sealing through repeated challenges while leaving corpse clearance unchanged, and protected cells must survive and produce differentiated progeny.
  2. 02Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearanceIn aged skin, local interleukin-1 (IL-1) amplification and wider antagonist spread could sustain inflammation despite restored corpse clearance. Measured reaction and diffusion parameters must predict recurring focus spacing, while an evenly mixed system remains stable.
  3. 03Collagen fragments keep skin inflammation active after normal corpse clearance returnsIn a neutrophil-replenished skin model with normalized corpse clearance, collagen fragments would sustain recurring inflammation. Removing proline-glycine-proline (PGP)-family peptides should stop recurrence, and adding them back at measured concentrations should restore it, even without living stromal cells.
One route per published explanation of this question. Where none is published yet, the answers the question itself could have.

Suppose this is what we see

Pick a result the work could return and read what follows from it: the explanation it would support, what the others predict for the same measurement, and what to check next.

Suppose
In donor-matched organotypic skin, macrophage-specific TIM-4 restoration increases engulfment of lineage-labelled, membrane-intact basal keratinocytes before irreversible death. Keratinocyte-restricted suppression of reversible phosphatidylserine exposure prevents this loss and restores repeated-challenge sealing while labelled apoptotic-neutrophil clearance remains unchanged. Protected keratinocytes must subsequently survive and contribute differentiated progeny; negative apoptosis markers alone are insufficient. Absence of rescuable live-cell engulfment, particularly if extracellular mediator interventions instead prevent recurrence, rejects this mechanism. Supposition
It supports
Restored corpse clearance can worsen aged skin by removing recoverable living cells — In donor-matched organotypic skin, restoring macrophage corpse clearance may remove living cells needed for repair. Protecting recoverable basal keratinocytes must restore sealing through repeated challenges while leaving corpse clearance unchanged, and protected cells must survive and produce differentiated progeny.
The others predict
  • Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance — After spatially uniform mild challenge and verified clearance normalization, inflammatory foci emerge at a reproducible nonzero spatial frequency. Independently measured reaction and diffusion parameters predict that frequency and its change when inhibitor distribution is altered. Spatially equalizing mediators while matching their mean concentrations suppresses recurrence; the corresponding well-mixed system remains stable. Failure to demonstrate homogeneous stability plus growth of a finite spatial mode rejects this Turing mechanism, even if cytokine blockade improves recovery.
  • Collagen fragments keep skin inflammation active after normal corpse clearance returns — In a neutrophil-replenished skin model with normalized efferocytosis, PGP-family peptide production precedes recurrent neutrophil activation and matrix damage. Selective peptide depletion or neutralization suppresses recurrence, and measured-concentration peptide add-back restores it. Activity remains demonstrable in a well-mixed transfer assay lacking viable stromal cells, unlike the proposed diffusion-driven pattern. Failure of depletion/add-back to control recurrence rejects this relay even if broad protease inhibition helps.
What to check next
After dead-cell removal is restored in aging skin, do barrier sealing, inflammation, and supporting-tissue organization remain recovered through repeated mild barrier challenges?

Choosing an answer changes this view only. No assessment moves and no explanation gains standing from it.

The explanations that compete for it

Each one was written for this question alone, and each names the observation that would settle it against the others.

01

Restored corpse clearance can worsen aged skin by removing recoverable living cells

Phagocytic target discrimination
What it says happens

In donor-matched organotypic skin, restoring macrophage corpse clearance may remove living cells needed for repair.

Full text

Restoring TIM-4-dependent corpse clearance in aged skin increases collateral engulfment of stressed but recoverable basal keratinocytes. Repeated barrier challenges transiently expose phosphatidylserine on these living cells; aged stromal inflammatory signals prolong that exposure. Macrophages consequently remove cells needed for resealing even while genuine apoptotic-corpse clearance remains normal. Recurrent cell loss sustains barrier leakage and downstream matrix damage. The causal defect is discrimination between recoverable cells and corpses, rather than insufficient clearance. Selectively protecting viable targets should stabilize SPV_1.

The prediction that separates it

In donor-matched organotypic skin, macrophage-specific TIM-4 restoration increases engulfment of lineage-labelled, membrane-intact basal keratinocytes before irreversible death.

Full text

Keratinocyte-restricted suppression of reversible phosphatidylserine exposure prevents this loss and restores repeated-challenge sealing while labelled apoptotic-neutrophil clearance remains unchanged. Protected keratinocytes must subsequently survive and contribute differentiated progeny; negative apoptosis markers alone are insufficient. Absence of rescuable live-cell engulfment, particularly if extracellular mediator interventions instead prevent recurrence, rejects this mechanism.

What would weaken it

Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance predicts instead: After spatially uniform mild challenge and verified clearance normalization, inflammatory foci emerge at a reproducible nonzero spatial frequency.

Full text

Independently measured reaction and diffusion parameters predict that frequency and its change when inhibitor distribution is altered. Spatially equalizing mediators while matching their mean concentrations suppresses recurrence; the corresponding well-mixed system remains stable. Failure to demonstrate homogeneous stability plus growth of a finite spatial mode rejects this Turing mechanism, even if cytokine blockade improves recovery.

Collagen fragments keep skin inflammation active after normal corpse clearance returns predicts instead: In a neutrophil-replenished skin model with normalized efferocytosis, PGP-family peptide production precedes recurrent neutrophil activation and matrix damage. Selective peptide depletion or neutralization suppresses recurrence, and measured-concentration peptide add-back restores it. Activity remains demonstrable in a well-mixed transfer assay lacking viable stromal cells, unlike the proposed diffusion-driven pattern. Failure of depletion/add-back to control recurrence rejects this relay even if broad protease inhibition helps.

02

Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance

Information and sensing
What it says happens

In aged skin, local interleukin-1 (IL-1) amplification and wider antagonist spread could sustain inflammation despite restored corpse clearance.

Full text

Aged stromal instruction supports a diffusion-driven inflammatory pattern: local IL-1 amplification induces a more widely distributed IL-1 receptor antagonist response, but their measured kinetics and effective spatial ranges permit persistent inflammatory foci despite normalized corpse clearance. The maladaptive state resides in a self-organized extracellular signal pattern, not a permanently activated macrophage. Restoring spatial stability of this circuit should stabilize SPV_1 and terminate the associated matrix-damage recurrence.

The prediction that separates it

After spatially uniform mild challenge and verified clearance normalization, inflammatory foci emerge at a reproducible nonzero spatial frequency.

Full text

Independently measured reaction and diffusion parameters predict that frequency and its change when inhibitor distribution is altered. Spatially equalizing mediators while matching their mean concentrations suppresses recurrence; the corresponding well-mixed system remains stable. Failure to demonstrate homogeneous stability plus growth of a finite spatial mode rejects this Turing mechanism, even if cytokine blockade improves recovery.

What would weaken it

Restored corpse clearance can worsen aged skin by removing recoverable living cells predicts instead: In donor-matched organotypic skin, macrophage-specific TIM-4 restoration increases engulfment of lineage-labelled, membrane-intact basal keratinocytes before irreversible death.

Full text

Keratinocyte-restricted suppression of reversible phosphatidylserine exposure prevents this loss and restores repeated-challenge sealing while labelled apoptotic-neutrophil clearance remains unchanged. Protected keratinocytes must subsequently survive and contribute differentiated progeny; negative apoptosis markers alone are insufficient. Absence of rescuable live-cell engulfment, particularly if extracellular mediator interventions instead prevent recurrence, rejects this mechanism.

Collagen fragments keep skin inflammation active after normal corpse clearance returns predicts instead: In a neutrophil-replenished skin model with normalized efferocytosis, PGP-family peptide production precedes recurrent neutrophil activation and matrix damage. Selective peptide depletion or neutralization suppresses recurrence, and measured-concentration peptide add-back restores it. Activity remains demonstrable in a well-mixed transfer assay lacking viable stromal cells, unlike the proposed diffusion-driven pattern. Failure of depletion/add-back to control recurrence rejects this relay even if broad protease inhibition helps.

03

Collagen fragments keep skin inflammation active after normal corpse clearance returns

Extracellular proteolytic relay
What it says happens

In a neutrophil-replenished skin model with normalized corpse clearance, collagen fragments would sustain recurring inflammation.

Full text

Normalized macrophage corpse clearance leaves a separate extracellular collagen-fragment relay active. MMP-8/9 and prolyl endopeptidase generate chemotactic PGP-family fragments; those fragments recruit and activate neutrophils that release further matrix-cleaving enzymes. Persistent biochemical fragment generation therefore renews inflammatory demand after each mild challenge, even when every cohort of apoptotic neutrophils is cleared normally. Selectively interrupting fragment generation or activity should stabilize SPV_3 and permit barrier recovery without replacing aged stroma.

The prediction that separates it

In a neutrophil-replenished skin model with normalized efferocytosis, PGP-family peptide production precedes recurrent neutrophil activation and matrix damage.

Full text

Selective peptide depletion or neutralization suppresses recurrence, and measured-concentration peptide add-back restores it. Activity remains demonstrable in a well-mixed transfer assay lacking viable stromal cells, unlike the proposed diffusion-driven pattern. Failure of depletion/add-back to control recurrence rejects this relay even if broad protease inhibition helps.

What would weaken it

Restored corpse clearance can worsen aged skin by removing recoverable living cells predicts instead: In donor-matched organotypic skin, macrophage-specific TIM-4 restoration increases engulfment of lineage-labelled, membrane-intact basal keratinocytes before irreversible death.

Full text

Keratinocyte-restricted suppression of reversible phosphatidylserine exposure prevents this loss and restores repeated-challenge sealing while labelled apoptotic-neutrophil clearance remains unchanged. Protected keratinocytes must subsequently survive and contribute differentiated progeny; negative apoptosis markers alone are insufficient. Absence of rescuable live-cell engulfment, particularly if extracellular mediator interventions instead prevent recurrence, rejects this mechanism.

Spatial inflammatory signals sustain recurring damage in aged skin despite restored clearance predicts instead: After spatially uniform mild challenge and verified clearance normalization, inflammatory foci emerge at a reproducible nonzero spatial frequency. Independently measured reaction and diffusion parameters predict that frequency and its change when inhibitor distribution is altered. Spatially equalizing mediators while matching their mean concentrations suppresses recurrence; the corresponding well-mixed system remains stable. Failure to demonstrate homogeneous stability plus growth of a finite spatial mode rejects this Turing mechanism, even if cytokine blockade improves recovery.

No test is published for this question yet

What stands in its place is above: each explanation states the measurement that would separate it from the others.

What to check next: After dead-cell removal is restored in aging skin, do barrier sealing, inflammation, and supporting-tissue organization remain recovered through repeated mild barrier challenges?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Does restored dead-cell removal stop skin damage after repeated challenges, or can aged surrounding tissue restart it?

What this question is asking

The question concerns whether restoring dead-cell removal can produce lasting recovery in aging human skin. It asks whether macrophages, immune cells that clear dead cells, can interrupt a proposed cycle in which damage to the skin’s protective barrier and its supporting material reinforces further damage. The competing possibility is that aged stroma, the surrounding support cells and material, restarts this cycle even while dead-cell removal remains normal during repeated mild challenges to the barrier. The intended comparison is lasting recovery versus returning damage, measured through barrier sealing, inflammation, and the arrangement of supporting material relative to young skin, ultimately over twenty years. The question assumes that this reinforcing cycle exists and that surrounding aged tissue might sustain it independently of defective clearance; the supplied sources do not establish that complete mechanism.

What the terms mean
Macrophage
An immune cell that can engulf dead cells and release signals affecting inflammation and repair. Macrophages can adopt overlapping patterns of activity; repair-associated activity is not a guarantee of normal tissue restoration.
Corpse clearance or dead-cell clearance
Removal of dead cells by other cells, including macrophages. Restoring deficient clearance means bringing impaired removal back toward a reference level; increasing clearance does not by itself establish that this has happened.
Skin barrier and barrier sealing
The skin’s protective boundary and the restoration of its ability to separate the body from the outside environment. The supplied input does not specify how successful sealing is measured.
Barrier challenge
An event that stresses or disrupts the skin’s protective boundary. The question specifies repeated mild challenges but supplies no method, strength, or interval.
Stroma or supporting tissue
The support cells and surrounding structural material within tissue. Aged stroma is an age-related tissue context, not one uniform cell type or a single established mechanism.
Extracellular matrix
Material outside and between cells that provides structural support. Its organization concerns how that material is arranged, which can differ between repaired tissue and a scar.
Barrier–matrix damage reinforcement
The proposed cycle in which barrier damage and disruption of supporting material help perpetuate one another, with inflammation connecting the steps. The supplied sources do not establish this complete cycle.
Inflammation and resolution
Inflammation is an immune response to injury or disturbance; resolution is the process by which that response subsides. Reduced inflammation does not by itself demonstrate restored tissue organization or lasting recovery.
Neutrophil
A type of immune cell involved in the wound response. The supplied sources discuss both its removal by macrophages and its persistence in aged wounds.
Fibroblast
A support cell that helps produce and maintain extracellular matrix. Fibroblasts are recipients of the altered macrophage communication described in S7.
Collagen
A structural protein in extracellular matrix. S4 reports more orderly collagen rebuilding, an outcome distinct from wound closure alone.
Scar formation
Repair that leaves altered supporting tissue rather than fully restoring the preceding tissue organization. S3 shows that increased dead-cell clearance can accompany this outcome.
Normal clearance and youthful recovery time ranges
Comparison standards for how effectively dead cells are removed and how quickly young skin recovers. The pipeline requires these standards but supplies no numerical definitions or measurement procedures.
What the question takes for granted
Premise only partly supported
Macrophage corpse clearance is a controllable contributor to a self-reinforcing barrier–matrix damage loop, and aged stroma may sustain or reinstate that loop independently of clearance.

Macrophages are immune cells that remove dead cells, while the skin barrier protects the body and the surrounding support cells and material help maintain tissue structure. The assumption is that damage to these parts feeds back on itself, with aged support tissue potentially keeping that process going even after dead-cell removal is restored. If established, this would make continued clearance and continuing tissue damage separable explanations for whether recovery lasts.

The sources support narrower components: increased dead-cell clearance accompanies repair-supporting macrophage changes in S1, support cells influence inflammation and produce structural material in S5, and aged wounds show persistent inflammatory cells and altered communication with support cells in S7. These findings do not establish a self-reinforcing barrier–matrix loop or show aged stroma restarting it after clearance is normalized. The supplied material also does not substantiate the gap detail’s specific assertion that existing clearance evidence establishes acute human resolution. Failure to establish these claims in the supplied sources does not show that they are false.S1S5S7

The same question asked without the part nothing read establishes:

  • After dead-cell removal is restored in aging skin, do barrier sealing, inflammation, and supporting-tissue organization remain recovered through repeated mild barrier challenges?
  • When dead-cell removal remains normal during repeated mild skin challenges, does recovery differ between aged and young surrounding support tissue?
What turns on the answer
  • Recovery persists while clearance stays normal Under the proposed mechanism, removing dead cells would interrupt enough of the inflammation-and-damage sequence for barrier sealing and supporting-tissue organization to recover repeatedly. If recovery continued within the time ranges seen in young skin, without progressively easier recurrence, clearance restoration would have met those functional criteria over the observed period. This would not by itself establish that every feature of skin aging had reversed.
  • Damage returns despite normal clearance Normal dead-cell removal would coexist with renewed barrier failure, inflammation, or disordered supporting material, showing that clearance restoration was insufficient for lasting recovery. Aged surrounding tissue would be a possible explanation within the question’s proposed mechanism, but recurrence alone would not establish that tissue as the cause.
  • Clearance deteriorates and damage returns The intervention would have failed to maintain the condition needed to distinguish the two main alternatives. Returning damage could still depend on defective dead-cell removal, so this outcome would not establish that aged surrounding tissue restarts damage independently of clearance.
Why it matters

In the proposed cycle, failure of the protective barrier contributes to inflammation, inflammation disrupts supporting tissue, and that disruption makes barrier recovery harder. Removing dead cells could interrupt a contributing source of inflammation, allowing recovery to continue. However, the supplied sources associate increased clearance with both repair-supporting changes and scar formation, so improved clearance alone cannot establish recovery of normal tissue organization [S1, S3]. If surrounding aged tissue restarts damage despite continued clearance, treating clearance as sufficient would mistake an early improvement for a lasting change. Conversely, lasting recovery through repeated challenges would support the narrower conclusion that continuing aged-tissue effects did not restart the measured damage under those conditions.

Still open

None of the supplied sources settles the central fork. The nearest work links clearance to repair-supporting changes or healing in S1 and S2, reports improved wound organization after a patch in S4, and describes altered inflammation and cell communication in aged wounds in S7. S3 supplies the important counterexample of enhanced clearance accompanying scar formation. The inference from this combination is that these repair findings cannot establish durable interruption of the proposed damage cycle; none tests recurrence under repeated challenges while clearance remains normal. This verdict applies to the supplied evidence, not to the absence of an answer throughout the literature.S1S2S4S7S3

What the literature establishes
  • S1 reports that a nerve-derived signal increases macrophage removal of neutrophils, a type of immune cell. Together with a separate direct effect on macrophage activity, this supports a shift toward reducing inflammation and supporting repair; the quote does not attribute the entire shift to clearance alone.S1
  • S2 reports that a wound treatment increases macrophage uptake of neutrophils and accompanies a shift toward repair-associated macrophage activity and improved healing. The supplied quote does not establish restored clearance in aging human skin or durability after repeated challenges.S2
  • S3 reports that a molecular signal increases macrophage dead-cell clearance and promotes a repair-associated activity pattern while also contributing to skin scar formation.S3
  • The supplied abstract excerpt for S4 reports wound closure, more orderly rebuilding of collagen, a structural protein, and reduced scar formation after application of a patch. That excerpt does not establish that clearance restoration alone caused these outcomes.S4
  • S5 reports that fat breakdown in skin fat cells affects inflammation and enables those cells to generate support cells that produce extracellular matrix, the structural material between cells. The supplied description identifies this as a mouse skin-injury study.S5
  • S7 reports more pronounced inflammation in aged skin wounds, including persistent neutrophils and a macrophage subgroup more likely to send inflammatory signals to fibroblasts, cells that help produce and maintain supporting material, than in young wounds.S7
What it does not settle
  • None of the supplied sources tests whether restoring deficient dead-cell clearance stops the proposed barrier–matrix damage cycle during repeated mild barrier challenges, or whether aged surrounding tissue restarts it while clearance remains normal.S1S2S3S4S5S6S7S8S9S10
  • The supplied evidence does not establish recovery in aging human skin within the time ranges seen in young skin, maintained over twenty years. It also supplies no operational definition of normal clearance, a mild challenge, or the recovery time ranges required for this comparison.
  • Whether damage lasts progressively longer, or progressively smaller challenges become sufficient to restart it, remains untested in the supplied descriptions.
  • The sources do not isolate aged surrounding tissue as a cause of recurrent damage independent of clearance. S5 establishes a role for support tissue in repair, and S7 describes age-associated wound changes, but neither performs the comparison in the question.S5S7
  • S8 concerns effects of macrophage-released substances on young fibroblasts grown outside the body, rather than restoration of clearance in intact aged skin. Its supplied quote is marked unverified, further limiting its evidentiary use.S8
  • The supplied evidence does not identify the smallest combination of changes sufficient to maintain a broadly youthful functional state across all the skin systems named in the gap detail.
Where the sources disagree
  • S3 reports increased dead-cell clearance alongside increased scar formation, whereas S1 and S2 associate increased clearance with repair-supporting changes or improved healing. This conflicts with a general assumption that more clearance necessarily produces less scarring or normal tissue organization. These are different settings and outcomes, so the contrast does not directly refute either source or resolve the repeated-challenge question.S1S2S3
Sources read · 10

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

CGRP sensory neurons promote tissue healing via neutrophils and macrophages. · Nature · 2024

“Meanwhile, CGRP increases neutrophil clearance by stimulating macrophage efferocytosis, which, together with a direct effect of CGRP on macrophage polarization, supports macrophages switching towards an anti-inflammatory and pro-repair phenotype.”

Does not settle: This source does not test repeated mild barrier challenges, aged stroma, barrier–matrix damage reinforcement, or whether normalized corpse clearance durably terminates or is reinstated by stromal effects.

S2Partly answers it

Skin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds. · Molecules (Basel, Switzerland) · 2021

“When anti-RAGE antibodies are applied to wounds in vivo, there is an increase in phagocytosis (efferocytosis) of neutrophils and a push towards a switch of macrophages to M2 phenotype, leading to improved healing, suggesting that high levels of AGEs in the wound impact the switch in phenotype and timely repair [ ].”

Does not settle: It does not test repeated mild barrier challenges, whether aged stroma reinstates a barrier–matrix damage feedback loop after clearance is normalized, or whether restored clearance terminates that loop.

S3Contradicts it

SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation. · Cell communication and signaling : CCS · 2024

“Our findings reveal that SHH can enhance oxidative phosphorylation (OXPHOS) in macrophages, augment macrophage efferocytosis, and promote M2 polarization, finally contributing to the progression of cutaneous scar formation.”

Does not settle: It does not test restoration of deficient corpse clearance, aged stroma, barrier–matrix damage reinforcement, or repeated mild barrier challenges.

S4Partly answers itAbstract only

Mechanically adaptive hydrogels reprogram apoptotic cell clearance to prevent tissue fibrosis. · Acta biomaterialia · 2026

“In vivo, the patch achieves near-complete wound closure (>95%) within two weeks, markedly reduces α-SMA+ myofibroblast accumulation, promotes ordered collagen remodeling, and substantially decreases scar formation.”

Does not settle: Whether clearance restoration terminates barrier–matrix damage reinforcement during repeated mild barrier challenges, or whether aged stroma reinstates it despite normalized clearance; the source does not establish effects in aged stroma or under repeated challenges.

S5Background

Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair. · Cell stem cell · 2020

“Our data reveal that adipocyte lipolysis plays a key role during tissue repair, allowing mature adipocytes to impact skin inflammation and generate extracellular matrix (ECM)-producing stromal cells.”

Does not settle: This mouse skin-injury study does not assess macrophage corpse clearance, restoration of clearance, aged stroma, repeated mild barrier challenges, or whether barrier–matrix damage reinforcement terminates or is reinstated.

S6Background

Topical ABT-263 treatment reduces aged skin senescence and improves subsequent wound healing. · Aging · 2024

“Figure 2. Increased dermal macrophage infiltration in aged skin treated with ABT-263.”

Does not settle: It does not assess macrophage corpse clearance, barrier–matrix damage reinforcement, repeated mild barrier challenges, or whether aged stroma reinstates damage after clearance is normalized.

S7Partly answers it

Wound healing in aged skin exhibits systems-level alterations in cellular composition and cell-cell communication. · Cell reports · 2022

“Our comparative study uncovers a more pronounced inflammatory phenotype in aged skin wounds, featuring neutrophil persistence and higher abundance of an inflammatory/glycolytic Arg1 Hi macrophage subset that is more likely to signal to fibroblasts via interleukin (IL)-1 than in young counterparts.”

Does not settle: This source does not test restoration or normalization of macrophage corpse clearance, repeated mild barrier challenges, barrier–matrix damage reinforcement, or whether aged stroma reinstates such reinforcement despite normalized clearance.

S8Partly answers itQuote unverified

Lipopolysaccharide-Activated Macrophages Suppress Cellular Senescence and Promote Rejuvenation in Human Dermal Fibroblasts. · International journal of molecular sciences · 2025

“Altogether, LPS-activated macrophages secrete factors that counteract SASP-induced senescence in young fibroblasts.”

Does not settle: This in-vitro conditioned-media study does not test restoration or normalization of macrophage corpse clearance, barrier–matrix damage reinforcement, aged stroma, or repeated mild barrier challenges.

S9BackgroundAbstract only

Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics. · Science translational medicine · 2022

“SRRMs provided a nonredundant function in clearing damage-induced apoptotic cells early after extensive acute injury.”

Does not settle: The abstract does not test restoration of corpse clearance, aged stroma, barrier–matrix reinforcement, or repeated mild barrier challenges.

S10Background

Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease. · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2019

“Targeting the intestine might provide novel therapeutic opportunities for CKD.”

Does not settle: This source does not test macrophage corpse clearance, aged stroma, repeated mild barrier challenges, or whether normalized clearance terminates or is followed by reinstatement of barrier–matrix damage reinforcement.

← Every open question